FDA should regulate marijuana due to youth schizophrenia risk

In his compelling piece, Greg Ganske highlights the dramatic increase in marijuana’s potency since the 1970s, noting THC levels have skyrocketed from 1-3% to often 20-30% or higher in modern products. This heightened potency poses mental health risks, particularly for adolescents, possibly accelerating the onset of conditions like schizophrenia. Ganske advocates for regulated federal legalization of cannabis to ensure safety and accurate labeling, echoing public health campaigns similar to those against tobacco and alcohol use.